Welcome To
Studies in Dermatology
For over 15 years, the Studies in Dermatology has been serving our patients with cutting edge new treatments for various dermatological and infectious diseases.
About Us
Lauren Campbell
Lauren Campbell, M.D., FAAD is a native Houstonian who grew up in the Cypress area and attended Jersey Village High School. She earned her undergraduate degrees in Spanish and Biology from the University of Texas at Austin, graduating with Highest Honors, and attended Houston’s prestigious Baylor College of Medicine with a full tuition scholarship. Dr. Campbell graduated from Baylor with Honors, and was inducted into the exclusive Alpha Omega Alpha Medical Honor Society. She matched into the competitive specialty of dermatology and completed her residency training at the Rush University Medical College in Chicago where she served as chief resident her senior year.
Dr. Campbell also spent a year at the University of Pittsburgh completing a dermatology fellowship specializing in pigmented lesions, melanoma, cutaneous T-cell lymphoma and participated in numerous clinical trials including cancer vaccine research trials.
Lilia Garcia
Lilia Garcia was born and raised in Puebla, Mexico. She moved to Houston, Texas at the age of eleven and has lived here since then. She became a Certified Medical Assistant in 2010 and worked in a nephrology clinic for four years. Subsequently, she started her clinical research career as a research assistant and worked her way up to now be the Clinical Research Manager for Studies in Dermatology, LLC. She continued her education and received a Bachelor’s of Science in Health and Behavioral Science from University of Houston Downtown, where she graduated magna cum laude.
Over the years, Lilia has conducted multiple trials for atopic dermatitis, psoriasis, HSV, warts, rosacea, and acne.
Get in touch
CURRENT STUDIES
A study that is intended to evaluate the safety and effectiveness of medications or medical devices by monitoring their effects on large groups of people. Studies may be conducted by government health agencies (such as the National Institutes of Health [NIH]), researchers affiliated with hospital or university medical programs, independent researchers, or individuals from private industry. Usually volunteers are recruited, although in some cases research participants may be paid. For some patients, clinical research trials represent an avenue for receiving promising new therapies that would not otherwise be available. Patients with difficult-to-treat or ‘incurable’ diseases may pursue participation in clinical research trials if standard therapies are not effective.
Clinical research is important in order to develop new therapies and diagnostic procedures as well as to understand how diseases develop. Observational studies may help identify risk factors for the development of a particular disease, such as the association between smoking and lung cancer. Outcomes-based research can help doctors identify the most effective therapies and treatments for a number of conditions. Another aspect of clinical research is the development of new technologies for use in health care, ranging from surgical tools and materials to hearing aids and artificial limbs.
The informed consent process is giving your consent to participate in the clinical trial after having learned about the trial and having had the opportunity to ask questions. You should be fully aware of all the details, risks vs. benefits, and expectations of the trial before agreeing to participate. When you give informed consent, you sign a document that describes the rights of the participants as well as gives details of the study and names of the investigators who are conducting the study and contact information for these people.
Clinical trials are required to maintain strict patient privacy. Your name will not be published anywhere that data about the trial are published or included in any publicly available information. Some clinical trials may require that you be seen and examined by a larger treatment team than would typical medical care. Studies in Dermatology follows the HIPPA Guidelines regarding patient privacy.
Each trial has specific inclusion and exclusion criteria to determine the exact patient populations that may participate. Individuals who fit the predefined and pre-approved inclusion criteria for a trial may participate if the trial is currently accepting participants. Inclusion criteria are based on factors such as patient age, gender, the type and stage of a disease, previous treatment history, and other medical conditions. Some clinical trials seek participants with illnesses or conditions to be studied in the clinical trial, while others need healthy participants.
Some clinical trials offer monetary compensation for participants. Other trials may offer their participants free health care that is related to the condition being studied, or screening examinations. There are no requirements for those who sponsor clinical trials to pay or otherwise compensate participants.
The benefits of clinical trials are many and range from taking an active role in the management of one’s own health care, helping others by aiding the process of knowledge acquisition and development of enhanced treatments, being cared for by leading health-care teams in a given field, and in some cases, receiving access to new treatments before they are approved. However, there are also risks, including side effects of drugs and risks of any procedures that may be performed. In some cases, clinical-trial participation may require more frequent doctor visits or hospitalizations than standard care, and you may have to travel to a study site that is farther away than your local health-care practitioner’s office.
Some questions you may want to ask before participating in a clinical trial include the following:
- What is the purpose of the trial?
- Is a new type of treatment being tested?
- How does this differ from the accepted or standard therapy for my condition?
- Has the drug or treatment ever been tested before?
- How will participation impact my daily life and schedule?
- Will it be necessary to be in the hospital?
- What are the risks and possible side effects of the treatment?
- Who will pay for the treatments?
- Will I receive reimbursement or any type of compensation for my time or expenses?
- How long is the trial expected to last?
- How will I receive results of the trial, and how will I know if the treatment is successful?
An informed consent document is not a legal contract that requires participation in a study for the length of a study. Participating in a clinical trial is completely voluntary and the participant is free to leave a clinical trial at any time.
Please call 281-377-6665
The researchers in the trial will stay in contact with participants and inform them of the conclusions of the trial. In some cases, you may be asked to provide long-term follow-up in the form of patient surveys or periodic health examinations. Since most clinical trials provide short-term treatments related to a specific condition, they are not a substitute for primary health care. Your regular health-care provider should be aware of the trial and will work with the researchers during the trial. When the trial is over, you will continue to receive care through your primary provider and any other practitioners required for your condition.